Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

The Changing of The Season

| Rob Coker | 3 min read

Ulrike Gnad-Vogt talks us through CureVac’s efforts to target seasonal influenza

Discovery & Development Drug Discovery

Flu Season: March of the mAbs

| Rob Coker | 3 min read

As the world continues to take on the post-COVID flu epidemic, we ask RQ Bio CEO Hugo Fry what part monoclonal antibodies play in new flu treatments

Discovery & Development Drug Discovery

How Data Sharing Can Upgrade AI for Pharma

| Robin Röhm | 5 min read

AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset

Discovery & Development Drug Discovery

Getting Creative with Rare Diseases

| Rob Coker | 9 min read

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments

Discovery & Development Drug Delivery

Connected Patient-Centricity

| Oliver Eden | 5 min read

How digital health technology can help clinical trials be more inclusive and accessible.

Discovery & Development Drug Discovery

The Blood Clot and the Invisible Frog

| Rob Coker | 2 min read

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

Discovery & Development Clinical Trials

Save One Person and You Heal the World

| Angus Stewart | 8 min read

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

Discovery & Development Dosage Forms

The Starch of Something Beautiful

| Angus Stewart

How a complex but common carbohydrate could help add a new dimension to 3D-printed pills

Discovery & Development Drug Discovery

Close the Care Gap

| Rob Coker | 9 min read

UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Discovery & Development Drug Delivery

Lethal Weapon

| Graeme Smith, Niall Martin | 6 min read

Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine